Plana M, Font J, Viñas O, Martorell J, Ingelmo M, Vives J
Servei d'Immunologia, Hospital Clínic i Provincial, Barcelona, Spain.
Clin Immunol Immunopathol. 1994 Aug;72(2):227-32. doi: 10.1006/clin.1994.1135.
To investigate whether the T cell defective capacity to proliferate observed in systemic lupus erythematosus (SLE) T cells is a possible consequence of an intrinsic T cell disorder, the integrity of the accessory activation pathway mediated through CD26 antigen in SLE T cells was studied. Hyporesponsiveness of peripheral blood mononuclear cells (PBMC) from SLE to PHA and CD26 Mab was observed and no differences were found when the responsiveness of highly purified T cells to IL-2, IL-2 plus CD26 Mab, phorbol 12-myristate 13-acetate (PMA), or when PMA plus CD26 Mab was analyzed. Findings suggest that signals induced by triggering CD26 are not intrinsically altered in SLE T cells. However, some alteration of the regulatory involvement of monocytes or B cell over T cell function may be involved.
为了研究在系统性红斑狼疮(SLE)T细胞中观察到的T细胞增殖缺陷能力是否是内在T细胞紊乱的可能结果,研究了SLE T细胞中通过CD26抗原介导的辅助激活途径的完整性。观察到SLE患者外周血单个核细胞(PBMC)对PHA和CD26单克隆抗体反应低下,当分析高度纯化的T细胞对IL-2、IL-2加CD26单克隆抗体、佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)或PMA加CD26单克隆抗体的反应性时,未发现差异。研究结果表明,在SLE T细胞中,触发CD26诱导的信号没有内在改变。然而,可能涉及单核细胞或B细胞对T细胞功能的调节参与的一些改变。